SCHEMBL15944101

SCHEMBL15944101

COC(C(=O)N(C)OC)c1ccc(NC(C)C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.43
RXFP1 Q9HBX9 1/20 0.39
KMT2A Q03164 4/20 0.38
TDP1 Q9NUW8 3/20 0.38
MEN1 O00255 3/20 0.38
RAB9A P51151 2/20 0.38
PKM P14618 1/20 0.38
ALDH1A1 P00352 5/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
LMNA P02545 2/20 0.34
CYP3A4 P08684 1/20 0.34
THRB P10828 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10329424 0.78 ALDH1A1 (0.46) FAAHKMT2APKMALDH1A1L3MBTL1
SCHEMBL2389196 0.78 FAAH (0.44) FAAHKMT2AMEN1ALDH1A1LMNA
SCHEMBL2387281 0.75 FAAH (0.51) FAAHTDP1PKMALDH1A1TSHR
SCHEMBL2389749 0.74 HIF1A (0.43) FAAHKMT2AMEN1RAB9APKM
SCHEMBL2387289 0.73 HIF1A (0.43) FAAHKMT2AMEN1RAB9APKM
SCHEMBL2391097 0.71 FAAH (0.39) FAAHALDH1A1
SCHEMBL21003615 0.71 FAAH (0.39) FAAHKMT2AMEN1RAB9AALDH1A1
SCHEMBL21003840 0.70 FAAH (0.38) FAAHKMT2AMEN1RAB9AALDH1A1
SCHEMBL9219793 0.70 ALDH1A1 (0.42) FAAHKMT2ATDP1MEN1RAB9A
SCHEMBL2386853 0.70 NNMT (0.42) FAAHKMT2AMEN1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140228581-A1 PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS OMEROS CORPORATION (US) 2014-08-14 US disclosed
US-20140228581-A1 PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS OMEROS CORPORATION (US) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228581-A1 PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS PDE10A, PDE9A, PDE7A FAAH 570/4885RXFP1 1405/4885KMT2A 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.